A single amino acid substitution in the murine norovirus capsid protein is sufficient for attenuation in vivo

D. Bailey, L. B. Thackray, I. G. Goodfellow

Research output: Contribution to journalArticlepeer-review

47 Scopus citations

Abstract

Murine norovirus (MNV), a prevalent pathogen of laboratory mice, shares many characteristics with human noroviruses. Previous results indicated that passage of MNV1 in the macrophage cell line RAW 264.7 results in attenuation in STAT1-deficient mice (C. E. Wobus, S. M. Karst, L. B. Thackray, K. O. Chang, S. V. Sosnovtsev, G. Belliot, A. Krug, J. M. Mackenzie, K. Y. Green, and H. W. Virgin, PLoS. Biol. 2:e432, 2004). Sequence analysis revealed two amino acid differences between the virulent and attenuated viruses. Using an infectious cDNA clone of the attenuated virus, we demonstrated that a glutamate-to-lysine substitution at position 296 in the capsid protein (VP1) is sufficient to restore virulence in vivo, identifying, for the first time, a virus-encoded molecular determinant of norovirus virulence.

Original languageEnglish
Pages (from-to)7725-7728
Number of pages4
JournalJournal of virology
Volume82
Issue number15
DOIs
StatePublished - Aug 2008

Fingerprint

Dive into the research topics of 'A single amino acid substitution in the murine norovirus capsid protein is sufficient for attenuation in vivo'. Together they form a unique fingerprint.

Cite this